Stock Analysis · Clicks Group Ltd (CLCGY)

Overview

Clicks Group is a South African retail healthcare company best known for its Clicks pharmacy and health-and-beauty stores, its dispensary network, and its fast-growing digital and omnichannel offering. The group also owns businesses that distribute medicines and healthcare products to hospitals, pharmacies, and other customers, which gives it a broader role in the healthcare supply chain than a typical retailer.

For long-term analysis, the key point is that Clicks operates in a part of healthcare that tends to be resilient: prescription medicines, over-the-counter products, personal care, and everyday health needs. That does not make the business immune to pressure, but it does mean demand is usually steadier than in many discretionary retail categories.

The latest annual reporting shows revenue is mainly driven by retail sales through Clicks stores and pharmacies, with wholesale and distribution making up the rest. A simple breakdown is:

• Retail sales: about 79% to 81% of group revenue. This includes front-shop health and beauty products, wellness items, household essentials, and pharmacy sales in Clicks stores.
• Wholesale and distribution: about 19% to 21% of group revenue. This largely comes from UPD, the group’s pharmaceutical wholesaling and distribution business, which supplies medicines and related products to the broader market.

That mix matters because retail generally brings stronger margins and customer loyalty, while distribution adds scale and strategic importance in medicine supply. Over the last several years, the company has also expanded store footprint, pharmacy capacity, and private-label penetration, which support profitability as well as sales growth.

The overall financial flow shows a business that has been growing revenue consistently, while gross profit has risen faster than sales over time. Operating profit and net income have also trended upward, suggesting the group has preserved discipline even while expanding its network.

Key Figures

Clicks stands out as a mid-sized healthcare retailer with unusually strong profitability and cash generation relative to much of its sector. The quality profile is solid, with returns on assets and long-term returns on invested capital well above typical sector levels. Growth metrics are also strong, especially over five years, helped by rising earnings, expanding free cash flow, and steady dividend growth.

The weaker area is market momentum. The stock has fallen sharply over the last year and now trades well below its recent highs and below its longer-term trend line. That disconnect is important: operating performance has remained fairly healthy, but market sentiment has clearly cooled.

Valuation measures in the table place the shares in a comparatively inexpensive range versus the broader healthcare sector. The combination of a lower earnings multiple, a low price-to-book ratio, and a dividend yield above sector median suggests the market is assigning a cautious view despite a business that still appears fundamentally profitable and cash generative.

Growth

Clicks operates in a structurally attractive segment. Retail pharmacy and everyday healthcare demand is supported by population growth, aging trends, chronic disease treatment, and recurring demand for wellness products. In South Africa specifically, formal pharmacy retail also benefits from gradual market share gains against informal channels and from demand for trusted brands, loyalty programs, and convenient store locations.

The company’s strategy appears coherent for long-term expansion. It continues to grow its store base, add pharmacies, and improve omnichannel reach. That matters because pharmacy-led retail benefits from density: more stores improve convenience, support prescription volumes, and strengthen supplier relationships. The group’s private-label offering is also important because own-brand products can improve margins and give customers a lower-priced option in a tough consumer environment.

Another useful growth lever is the link between retail and wholesale. Clicks is not only selling to end customers; it also participates in pharmaceutical distribution through UPD. This adds scale and makes the group more embedded in the healthcare ecosystem, although distribution usually carries thinner margins than retail.

Recent annual reporting points to continued sales growth, stronger cash generation, and ongoing network expansion. Those are meaningful signals because they show the company is still executing even in a pressured consumer backdrop. A further catalyst is that healthcare spending is less cyclical than many other retail categories, so Clicks can continue compounding through both volume growth and selective margin improvement if execution remains steady.

Risks

This article is for informational purposes only and does not constitute financial advice. Some content is AI-generated. See Disclaimer